
Alcon Announces Launch of AcrySof IQ Vivity in India

Alcon Announces Launch of AcrySof IQ Vivity in India, the First and Only Presbyopia-Correcting Lens Implant with Proprietary Wavefront-Shaping Technology for Cataract Surgery
New Delhi (India), January 7: Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology – the AcrySof® IQ Vivity® IOL (Vivity®). This new PC-IOL is now available to Indian ophthalmologists for their patients undergoing cataract surgery. Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.
Vivity is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE technology, which stretches and shifts light without splitting it. Vivity delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on a laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances. Commemorating World Sight Day on October 14, Vivity aims to meet the needs of cataract patients interested in enhanced visual performance, reduced spectacle dependence while enabling more independence.
Vivity expands Alcon’s growing portfolio of PC-IOLs and is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally. According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision. Additionally, 94% and 92% of Vivity patients reported superior vision at distance and arm’s length, respectively, without glasses in bright light.
Cataracts are the most common cause of vision loss globally and the primary cause of preventable blindness in India. Cataract surgery involves removing the clouded natural crystalline lens followed by a replacement with an intraocular lens (IOL). The prevalence of cataracts in India is 9.9 million; each year, 6.5 million surgeries are performed by around 12,200 cataract surgeons.
Among the 6.5 million undergoing cataract surgery in India, 90% of patients continue to depend on glasses for most of their daily activities even after surgery. An independent survey revealed that 95% of these patients expressed the willingness to get rid of glasses after the surgery. Sadly, despite the desire, there are several barriers. One of the significant barriers is the limitation of the current technology to address the visual needs of all patient groups.
“Traditional IOLs typically address distance vision. The new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India Pvt Ltd. “Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.
Vivity is the first and only non-diffractive* presbyopia-correcting IOL with minimum visual disturbance profile. Unlike conventional presbyopia-correcting IOLs, which split light, Vivity utilizes almost all light energy, providing good vision quality in all lighting conditions. Vivity is approved by the Central Drug Standard Control Organization (CDSCO).
Leading ophthalmic surgeons worldwide who have had a chance to implant Vivity have said that they can now offer presbyopia correction to a more significant number of patients undergoing cataract surgery, with strong satisfaction rates. Based on a recent survey, 93% of patients said they would definitely recommend the new AcrySof Vivity to their friends and relatives.
Receive and send emails through your temporary messaging system. Use our webmail or your favorite email software with our absolutely free disposable email. temp mail
Spot on with this write-up, I honestly think this website needs a great deal more attention. I’ll probably be
back again to see more, thanks for the info!
Thanks for sharing such a good idea, piece of writing is pleasant,
thats why i have read it fully
Heya i’m for the first time here. I found this board and I
find It really useful & it helped me out much. I hope to
give something back and aid others like you helped me.
I was suggested this blog by my cousin. I am not sure whether this post is
written by him as no one else know such detailed
about my difficulty. You’re incredible! Thanks!
Hi, I would like to subscribe for this webpage to
take most recent updates, therefore where can i do it please help.
After going over a number of the articles on your web site, I really like your technique of writing a
blog. I added it to my bookmark website list and will
be checking back soon. Please check out my website
as well and tell me how you feel.
Hello there! I know this is kinda off topic
but I was wondering which blog platform are you
using for this site? I’m getting fed up of WordPress because I’ve
had problems with hackers and I’m looking at alternatives for another
platform. I would be fantastic if you could point me in the direction of a good
platform.
Hi there, its good paragraph about media print, we all
understand media is a fantastic source of facts.
Hi, constantly i used to check webpage posts here early in the dawn, because i enjoy
to learn more and more.
Great post however , I was wanting to know if you could write a litte more on this topic?
I’d be very thankful if you could elaborate a little bit more.
Thanks!
Hello to all, how is everything, I think every one is getting more from this website,
and your views are fastidious designed for new users.
Excellent post. I will be dealing with some of these issues as well..
have demonstrated that E2 E6 or E2 E7 is less sensitive and predictive than E2 E6E7 for determination of physical status of HPV genome in cervical cancer 54 nolvadex pct side effects
99 Month 149 Month 199 Month 299 Month 2, 000 24 2, 376 15 2, 556 11 2, 736 7 2, 093 3, 000 39 3, 861 23 3, 427 17 3, 383 11 3, 289 how to buy priligy in usa